Dr. Maria V. Suurna, MD

Dr. Suurna practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Suurna's NPI, 1609095918, was assigned on April 25, 2007. Dr. Suurna graduated from Indiana University School Of Medicine in 2004. Dr. Suurna holds Florida license ME155641.

Dr. Suurna's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Suurna's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Suurna to 4 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Suurna practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Suurna's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Suurna is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Suurna's licenses on file in 3 states: Florida, New York and Ohio.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, endoscopic sinus surgery, hearing loss and impairment, swimmer's ear and tinnitus among the conditions Dr. Suurna treats.

CMS data shows 288 Medicare services from Dr. Suurna across 6 procedure codes in 2024, for 189 Medicare patients. Medicare paid $20,636 for them.

CMS counts 189 Medicare patients who saw Dr. Suurna in 2024. The largest group is 65 to 74, with 107 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Suurna's median patient age at 66, with 40% women.

In 2024, Dr. Suurna wrote 305 Medicare Part D claims for 100 patients. 98% of them were for generic drugs. CMS names the drug for 214 of them, across 3 drugs with 11 or more claims each, at $5,070 in total drug cost. In 2023, CMS named 189 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Suurna for performance year 2024, reported as part of a group. Dr. Suurna accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Suurna as offering telehealth.

Dmand AI links 50 papers to Dr. Suurna, published from 2006 to 2025. 2020 was the busiest year, with 8. The most frequent topics are Sleep Apnea, Obstructive, Electric Stimulation Therapy and Hypoglossal Nerve. Dr. Suurna has published most often in Laryngoscope. Dr. Suurna's most frequent co-authors are Stacey L. Ishman, MD, David Tambling Kent, MD and Ryan Jeremy Soose.

Dmand AI links Dr. Suurna to 3 clinical trials. 3 are still active or recruiting. Conditions studied include Sleep Apnea, Obstructive and Sleep Apnea Syndromes. Inspire Medical Systems, Inc. sponsors the most, 2.

CMS Open Payments shows 279 general payments to Dr. Suurna from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 63% of the total. Inspire Medical Systems, Inc. paid the most, $161,444.

Dmand AI lists 3 awards for Dr. Suurna, most recently CMS Stage 1 EHR in 2012.

Dr. Suurna graduated from Indiana University School Of Medicine in 2004. Dr. Suurna is a member of NHS and ACS.

Dr. Suurna is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.